PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)

NCT01377662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Methamphetamine Dependence
Cocaine Dependence

Interventions

DRUG: OND-PR002 and MPh-IR
OTHER: Placebo: Two dextrose capsules for Ond-PR002 and MPh-IR

Sponsor

Tong Lee

Collaborators

[object Object]
[object Object]